fbpx
QQQ
+ 0.84
303.01
+ 0.28%
DIA
+ 1.17
297.99
+ 0.39%
SPY
+ 0.37
366.45
+ 0.1%
TLT
+ 1.12
155.14
+ 0.71%
GLD
+ 1.19
170.34
+ 0.69%

A Right-Leaning Supreme Court Won't Impede Cannabis Reform, Legal Experts Say

November 20, 2020 12:23 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Justice Amy Coney Barrett's Oct. 27 confirmation to the Supreme Court may feel like ages ago after a historic election season complicated by President Trump's attempts to reverse the results.

Under a month into the role, Justice Barrett stands poised to weigh in on a myriad of pressing issues, including voting rights, the census and the fourth amendment.

Cannabis reform likely won't be one of those matters, legal experts say.

Related link: Federal Measures To Protect Cannabis Users In Legal States Head To House Floor

A Conservative Court Unlikely To Impact Reform Efforts Much

While the Barrett appointment leans the court considerably conservative, it is unlikely to impact the ongoing Green Wave.

"Unless a party can formulate an argument that the scheduling of cannabis is unconstitutional…the question is unlikely to reach the Supreme Court anytime soon," Jodi Avergun, Cadwalader Wickersham and Taft's chair of white collar defense, says.

The Supreme Court refused to hear cannabis classification cases in the past, namely an October 2020 case brought up by several medical patients, including Alexis Bortell, Marvin Washington and Jose Belen.

Avergun, the former chief of staff at the DEA and former chief of the narcotic and dangerous drug section of the Justice Department's criminal division, said the case was not indicative of future cannabis decision making.

She said the court rejecting the case, which sought to force the DEA to take action on a rescheduling petition, sets no precedential value.

"Moreover, that case is not terribly instructive because it focused more on agency rulemaking than the substantive question of cannabis reform," added Avergun.

Clark Hill group's Senior Counsel Michelle R. E. Donovan says litigants need to seek administrative relief necessary petitions to the DEA and HHS first to reschedule its classification.

"Until this is done, cannabis will remain illegal under federal law, and continue to bring about associated federal problems for the cannabis business, while States scramble for legislative remedies for a booming market," Donovan says.

Related link: Which State Cannabis Markets Best Represent A Possible Federal Legal Framework?

Unlikely Pathway To Reform Through The Judicial Branch

Sources say cannabis reform will almost assuredly pass through the Legislative Branch before ever reaching the Supreme Court.

Avergun doesn't see a change in that prospect, though there is potential if Chevron deference is overruled or limited in some fashion.

"The Court will not defer to DEA's judgment's about legality, but any cannabis case before the court will not likely be grounded in regulatory action, so Chevron deference or limits thereon probably will not help here," Avergun added.

Cannabis decisions have found their way to the Supreme Court in the past. Recall 2005's Gonzales v. Raich, which ruled for the regulation or banning of compliant in-state cannabis cultivation through the Commerce Clause.

Marijuana Policy Project's Director of Government Relations Chris Lindsey said the 2005 ruling is rare for cannabis. However, policy change could give way to court action, according to Lindsey.

"Perhaps once a MORE Act or another legalization measure passes, the makeup of the Court will have a big impact on its treatment should it face challenges, but it is hard to know how that might play out," Lindsey says.


Related Articles

Gaby Buys Mankind Cannabis Dispensary For $36.5M, Confirms $8.5M Private Placement

Shares of GABY Inc. (OTCQB: GABLF) are trading up almost 6% on Thursday afternoon, after the cannabis company announced a merger with Mankind Dispensary, one of the first licensed dispensaries in California. read more

420 Investor: 'This Is The Most Excited I've Ever Been' In Cannabis

Alan Brochstein, author of 420 Investor and founding partner of New Cannabis Ventures, says the recent political momentum behind the cannabis legalization push in the US — and the resulting rebound in cannabis stocks since the U.S. election — has him feeling extremely optimistic about the industry's future. read more

Canadian Cannabis Stocks Are Becoming Less Desirable Investments, Data Suggests

Cannabis stocks have taken a hit since Election Day, Nov. 3. The latest Hifyre cannabis sales data out of Canada suggests some concerning trends in the market. The Numbers: Month-over-month, Canadian retail cannabis sales were up just 4% in October and down 3% in November, Hifyre estimates. read more

New Cannabis Products: A Hemp Spirit, A New Jane West Collab, CBD From Citrus Peels

As the cannabis market expands, it's hard to keep track of the many products that launch every week. Benzinga put together a short list of some of the most interesting new cannabis products. read more

Acreage Ensures $12M Loan To Expand Illinois Facility

Acreage Holdings Inc. (OTCQX: ACRHF) revealed it is getting a $12 million construction financing loan to support the development of its cultivation and processing facility in Illinois. read more